Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06399640
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2024-04-30
Brief Title:
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Vanderbilt-Ingram Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Acute Myeloid Leukemia |
| Relapsed Myelodysplastic Syndrome |
| Refractory Myelodysplastic Syndrome |
| Acute Myeloid Leukemia |
| Recurrent Acute Myeloid Leukemia |
Keywords: